The FH Foundation is a patient-centered non-profit dedicated to research, advocacy, and education of all forms of familial hypercholesterolemia


Screen Shot 2016-11-18 at 11.47.48 AM

Treating High Cholesterol Is a Family Affair: My Life With FH

By Erinn Connor
Medically Reviewed by Robert Jasmer, MD

For original article visit:

One patient with familial hypercholesterolemia took action after too many in her family died of heart attacks in their … Read More

FHF_Newsletter_Summit_Header_11-9-16 - V2

Translational Medicine in Familial Hypercholesterolemia

October 17-18, 2016 | Dallas, TX

The FH Foundation’s 2016 FH Global Summit took place a stone’s throw away from the Brown/Goldstein Lab, where the LDL receptor was discovered.

In attendance were a group of over 250 committed … Read More


What Gets Measured Gets Done: Public Health Progress in Familial Hypercholesterolemia

Just 4 years ago, one of us (MJK) co-chaired the Familial Hypercholesterolemia (FH) Foundation’s first FH Global Summit: Awareness to Action held in Annapolis, Maryland. The Summit brought together people from academia, government, the private sector, clinicians, as well as patients with the ambitious goals of raising … Read More


Bococizumab – What does it mean for FH patients?

What Does News of Pfizer’s Discontinuation of PCSK9 Inhibitor Program Mean for FH Patients?

With the news that Pfizer, Inc has discontinued development of its PCSK9 inhibitor, bococizumab, the FH Foundation reached out to our Chief Scientific Advisor, Dan Rader, MD, Seymour Gray Professor of Molecular Medicine … Read More

Screen Shot 2016-10-07 at 8.31.30 AM

FH Advocate Talks about Lifetime Management HoFH at CMHC

FH Advocate for Awareness, Allison Jamison, joined FH Foundation Scientific Advisory Board Member Dr. James Underberg (Clinical Assistant Professor of Medicine NYU Medical School & NYU Center for CV Prevention, Director Bellevue Hospital Lipid Clinic, President-Elect NLA) to speak about her experience living with … Read More